Company

NORTHWEST BIOTHERAPEUTICS INC (NWBO)

Standardized SEC financial data for NORTHWEST BIOTHERAPEUTICS INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001072379 · OTC · Pharmaceutical Preparations.

Gross margin

58.7%

Operating margin

-1000.0%

Net margin

-1000.0%

Revenue growth (YoY)

-0.3%

Return on equity

99.8%

Free cash flow

-$46.3M

Debt / equity

-1.00×

Current ratio

0.06×

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.3M	$1.0M	$1.7M	$1.9M	$1.4M	$1.4M
R&D expense	$33.6M	$20.3M	$35.5M	$27.7M	$34.9M	$28.8M
SG&A expense	$54.3M	$33.4M	$33.4M	$29.7M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$10.0M	$15.2M	$7.0M	$2.1M	$2.2M	$3.0M
Total current assets	$15.5M	$17.3M	$9.4M	$4.1M	$4.1M	$5.5M
Property, plant & equipment	$1.0M	$15.0M	$13.4M	$17.3M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$32.1M	-$38.3M	-$52.8M	-$53.6M	-$57.0M	-$44.8M
Capital expenditures	—	—	—	—	$1.0M	$1.5M
Free cash flow	—	—	—	—	-$58.0M

Get NWBO data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/NWBO/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/NWBO/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View NWBO filings on SEC EDGAR →